Similarly, reduced viability was observed in a panel of melanoma BRAF-mutated cells (MM96L, A2058, HTT144, JA, SKMEL28 and A02) at 50 μg/mL, with a more profound effect observed for HiGom (Supplementary Fig. 2). The gene discussed is BRAF; the disease is melanoma.